Tender Results of Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final possibility for the combination of active substances Fusidic acid/Betamethason (ATC code according to WHO: D07CC01)
Contract Date2 Jul 2019
Contract AmountRefer Documents 

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active substance fentanyl as oral administration (ATC code according to WHO: N02AB03)
Contract Date2 Jul 2019
Contract AmountRefer Documents 

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Non-exclusive drug discount agreements according to § 130a para. 8 SGB W with any final option for the active substance fosfomycin (ATC code according to WHO: J01XX01)
Contract Date2 Jul 2019
Contract AmountRefer Documents 

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active ingredient Somatropin (ATC code according to WHO: H01AC01)
Contract Date1 Jul 2019
Contract AmountRefer Documents 

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Non-exclusive drug discount agreements according to § 130a para. 8 SGB W with any final possibility for the active ingredient Glatirameracetate in the active strength 20 mg (ATC code WHO: L03AX13)
Contract Date1 Jul 2019
Contract AmountRefer Documents 

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Non-exclusive drug discount agreements according to § 130a para. 8 SGB W with any final option for the active substance Fulvestrant (ATC code according to WHO: L02BA03)
Contract Date3 Jun 2019
Contract AmountRefer Documents 

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active ingredient Bimatoprost (ATC code according to WHO: S01EE03)
Contract Date3 Jun 2019
Contract AmountRefer Documents 

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final possibility for the active substance combination Benazepril/HCT
Contract Date3 Jun 2019
Contract AmountRefer Documents 

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active substance methyldopa (ATC code according to WHO: C02AB01)
Contract Date28 May 2019
Contract AmountRefer Documents 

Aok Plus Die Gesundheitskasse Fur Sachsen Und Thuringen Tender Result

Result Stage: Awarded  (AOC Available)
Germany
Non-exclusive drug discount agreements according to § 130a para. 8 SGB V with any final option to the active ingredient Octreotid (ATC code: H01CB02)
Contract Date28 May 2019
Contract AmountRefer Documents 
81-90 of 209 active Tender Results